BDBM50310610 CHEMBL1079150::N-(4-(2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl)phenyl)benzo[d]oxazol-2-amine
SMILES: C(Cc1ccc(Nc2nc3ccccc3o2)cc1)Nc1ncnc2ccsc12
InChI Key: InChIKey=STXFSYACLJLVGM-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurora kinase B (Homo sapiens (Human)) | BDBM50310610 (CHEMBL1079150 | N-(4-(2-(thieno[3,2-d]pyrimidin-4-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents | Article PubMed | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Sunesis Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Inhibition of Aurora B after 60 mins | Bioorg Med Chem Lett 19: 5158-61 (2009) Article DOI: 10.1016/j.bmcl.2009.07.016 BindingDB Entry DOI: 10.7270/Q2T72HK2 | |||||||||||
More data for this Ligand-Target Pair |